Forging A Path to HCV Elimination: Simpler Tests and Affordable Generics: Report of the World Community Advisory Board on HCV Generics and Diagnostics 18-20 July 2017, Bangkok, Thailand “In July 2017, 37 treatment activists from 17 countries—including 14 low- and middle-income countries (LMICs)—met with representatives from three generics and three diagnostics Read more…
https://www.cdc.gov/hepatitis/policy/pdfs/NationalProgressReport.pdf “On October 27, the U.S. Centers for Disease Control and Prevention (CDC) published an online report entitled Progress Toward Viral Hepatitis Elimination in the United States. In this inaugural report, CDC highlights recent progress made by the nation towards reducing the burden of hepatitis A virus, hepatitis B virus, Read more…
http://www.natap.org/2017/AASLD/AASLD_25.htm The US Department of Veterans Affairs presented data on effectiveness of at the 2017 AASLD Liver meeting. View slides at the link above.
HepVu is an interactive online resource that visualizes the first standardized state-level estimates of people with past or current Hepatitis C infection across the United States. These estimates were generated by Emory University’s Coalition for Applied Modeling for Prevention (CAMP), a project supported by the Centers for Disease Control and Read more…
NASTAD highlighted hepatitis ending the epidemic success stories from this year. Philadelphia was the latest in its campaign! “NASTAD is a leading non-partisan non-profit association that represents public health officials who administer HIV and hepatitis programs in the U.S. and around the world. Our singular mission is to end the Read more…
“Washington, D.C. – Research presented this week at The Liver Meeting® – held by the American Association for the Study of Liver Diseases – shows people in treatment for opioid substance abuse significantly lowered their non‐prescribed opioid use after testing positive for hepatitis C virus.” Read full report: https://www.aasld.org/about-aasld/press-room/screening-hepatitis-c-improves-opioid-abuse-treatment-outcomes
Hepatitis C: State of Medicaid Access is the culmination of work by the Center for Health Law and Policy Innovation of Harvard Law School (CHLPI) and the National Viral Hepatitis Roundtable (NVHR) to definitively assess the state of access to DAAs for Medicaid enrollees across America. Through a national report Read more…
https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-017-0192-8 New article from the Harm reduction journal about improving HCV treatment successes.
What’s New, Updates, and Changes to the Guidance This version of the guidance has been updated to reflect several important developments, including the recent approvals of glecaprevir/pibrentasvir and sofosbuvir/velpatasvir/voxilaprevir. Updated recommendations reflecting these approvals are provided throughout the guidance. In addition to updates to all the sections, the following new Read more…
http://www.nationalacademies.org/hmd/Activities/PublicHealth/NationalStrategyfortheEliminationofHepatitisBandC.aspx “This consensus committee will explore the elimination of hepatitis B and C from the United States. The committee is working in two phases. First, they considered the feasibility of elimination as a goal, with attention to social and logistical aspects of feasibility as well as scientific ones. The phase Read more…